Glycerol restores heat-induced p53-dependent apoptosis of human glioblastoma cells bearing mutant p53 by Ohnishi, Takeo et al.
BioMed  Central
Page 1 of 8
(page number not for citation purposes)
BMC Biotechnology
BMC Biotechnology  2002,  2 x Research article
Glycerol restores heat-induced p53-dependent apoptosis of human 
glioblastoma cells bearing mutant p53
Takeo Ohnishi*, Ken Ohnishi and Akihisa Takahashi
Address: Departments of Biology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8521, Japan
E-mail: Takeo Ohnishi* - tohnishi@nmu-gw.naramed-u.ac.jp; Ken Ohnishi - kohnishi@nmu-gw.naramed-u.ac.jp; 
Akihisa Takahashi - atakahas@nmu-gw.naramed-u.ac.jp
*Corresponding author
Abstract
Background: We have previously reported that glycerol acts as a chemical chaperone to restore
the expression of WAF1 in some human cancer cell lines bearing mutant p53. Since the expression
of WAF1 is up-regulated by activated wildtype p53, glycerol appears to restore wtp53 function.
The aim of the present study is to examine the restoration of heat-induced p53-dependent
apoptosis by glycerol in human glioblastoma cells (A-172) transfected with a vector carrying a
mutant p53 gene (A-172/mp53 cells) or neo control vector (A-172/neo cells).
Results: A-172/mp53 cells showed heat resistance compared with A-172/neo cells but A-172/
mp53 cells in turn became heat sensitive when pre-treated with glycerol before heat treatment.
The accumulation of Bax in the A-172/mp53 cells was induced by heating with glycerol pre-
treatment, but not without it, whereas the accumulation in the A-172/neo cells was induced in both
cases. Furthermore, mp53 extracted from heated cells came to bind to the sequence specific region
after heating combined with glycerol pre-treatment. The phosphorylation of mp53 at serine15 was
suppressed by an inhibitor of the phosphatidylinositol 3-kinase (PI3-K) family.
Conclusion: These results suggest that glycerol is effective in inducing conformational change of
phosphorylated p53 and restoring mp53 to wtp53 function, leading to enhanced heat sensitivity
through the induction of apoptosis. This novel tool for enhancement of heat sensitivity in cancer
cells bearing mp53 may be applicable for p53-targeted hyperthermia, because mutation or
inactivation of p53 is observed in approximately 50% of human cancers.
Background
It is known that p53 induces cell growth arrest [1,2] or cell
death [3] and the suppression of DNA replication [4] to
suppress the initiation, progression or growth of tumor.
p53 exhibits its function through the induction of down-
stream genes and/or protein interaction relating to tumor
suppression. However, mutations in the p53 gene cause
conformational alterations in p53 protein and the major-
ity of mp53 can no longer induce expression of down-
stream genes [5,6]due to sequence specific DNA binding
inability. Heat up-regulates sequence specific DNA bind-
ing activity of wtp53 [7] and induces the expression of
p53-regulated gene [8]. Thus, hyperthermia is regarded as
a good tool for cancer therapy from the view of suppres-
sion of tumor growth. We have already reported that
wtp53-transfected  p53-knockout cells show higher inci-
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dence of apoptosis by heat compared with mp53-trans-
fected  p53-knockout cells [9]. Furthermore, patients
bearing wtp53 show a high survival rate after radiotherapy
resulting from Bax and Bcl-2 regulation [10,11]. Such
hyperthermia/radiotherapy based on p53 status, however,
seems to have some difficulties for the treatment of cancer
cells bearing mp53. To overcome this problem, we
present here a new strategy for cancer therapy. In recent
years, glycerol has been reported to act as a chemical chap-
erone to correct the conformation of proteins, which
cause human diseases [12,13]. Consistent with this, we
have reported that glycerol acts as a chemical chaperone to
restore the expression of WAF1 in some human cancer cell
lines bearing mp53[14] and to restore apoptosis in p53-
knockout mouse fibroblast cells transfected with
mp53[15]. Since the expression of WAF1 is up-regulated
by activated wtp53, glycerol appears to restore wtp53
function. In the present study, we further examined the ef-
fect of glycerol on p53-dependent apoptosis induction
through bax expression and whether the heat sensitivity of
cells bearing mp53 is enhanced by glycerol. To enable a
discussion of the results on the basis of p53 status only, we
transfected A-172 cells with the mp53 gene, which had
identical genetic backgrounds except for p53 status, and
demonstrated so-called "dominant negative effect" of
mp53 protein [16,17].
Recently, it was reported that the PI3-K family such as
ATM, ATR and DNA-PK contributes to the activation of
p53 through the phosphorylation of serine 15 of p53 [18–
22]. In the present study, to gain further insight into the
mechanism of restoring mp53 to wtp53, we examined
mediation of the phosphorylation of p53 by the PI3-K
family to conformational change of mp53.
Results and Discussion
To elucidate the effect of glycerol on the heat sensitivity of
transformed A-172 cells, the clonogenic surviving frac-
tions by heat after pre-treatment with or without glycerol
(0.6 M) were measured. As shown in Fig. 1a, A-172 cells
tranfected with mp53 (val to ala at codan 143) (A-172/
mp53/143 cells) were more resistant to heat than the A-
172/neo cells. By glycerol treatment, A-172/mp53/143
cells became about 1.5 times more heat-sensitive at D10
dose, whereas A-172/neo cells showed no enhanced heat
sensitivity. In addition, A-172/mp53/143 and A-172/neo
cells treated with glycerol alone (0.6 M) showed about
80% survival fractions, and thus the concentration of glyc-
erol appeared to cause no serious cell damage regardless
of p53 status. These results suggest that glycerol affects the
heat sensitivity of those cells in a way that it enhances heat
sensitivity in mp53 cells.
The change of cellular contents of Bax after heating was
analyzed in A-172/mp53/143 cells with Western blot. As
shown in Fig. 1b, Bax was accumulated after heating in the
presence of glycerol at 0.6 M, although Bax accumulation
was not induced after heating alone or treatment with 0.6
M glycerol alone in the cells. It is possible that mp53
might function as a transcriptional factor in heat-induced
Bax accumulation under the presence of glycerol. In addi-
tion, A-172/mp53/143 cells only heated accumulated
large amounts of p53 but no significant Bax, suggesting
that heat treatment induces accumulation of mp53 as is
the case in human glioblastoma A-7 cells [23]. The accu-
mulation of mp53 is probably due to the elongation of its
half-life by heat. Glycerol alone treatment may not be suf-
ficient to convert mp53 into wtp53 because this treatment
Figure 1
a, Clonogenic survival rates of cells after heating or combina-
tion treatments with glycerol. Two duplicate flasks were
used per experiment, and two or more independent experi-
ments were repeated for each survival point. Open square,
A-172 neo contol cells; closed square, neo control cells pre-
treated with 0.6 M glycerol; open triangle, A-172/mp53/143
cells; closed circle, A-172/mp53/143 cells pretreated with 0.6
M glycerol. b, Restoration by glycerol of heat-induced Bax
accumulation in A-172/mp53/143 cells. Western blotting
samples were prepared from cells 10 h after heating at 44°C
for 30 min. The glycerol was added 48 h before heating at a
final concentration of 0.6 M. Glycerol was present in the
medium during culture after heating.
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did not lead to accumulation of endogenous latent wtp53
and did not induce Bax accumulation in A-172/mp53/143
cells. This also excludes the possible involvement of os-
motic stress-induced signal transduction in the p53 path-
way. We assumed that denaturation by heat stress may
disrupt the aberrant conformation of the p53 mutant, and
glycerol may exert its effect during renaturation to stabi-
lize the transient wtp53 conformation that is otherwise
very unstable. Subsequently, the conformation-stabilized
p53 could be activated as a transcriptional factor by heat-
induced signal transduction. Thus, the inability to induce
Bax accumulation by glycerol alone may be due to mutant
conformation of p53.
Glycerol treatment alone was insufficient to induce Bax
accumulation (Fig. 1b). This result led us to assume that
some initial signals evoked by heating are required to ef-
fectively induce signals leading to apoptosis. Thus, we
next examined the activation of mp53 through phospho-
rylation after heat and glycerol treatments. It has been re-
ported that the phosphorylation of serine 15 of p53 by the
PI3-K family induces p53 activation [18–22]. Therefore,
we estimated the activation of mp53 based on the induc-
tion of WAF1 which is one of downstream factors regulat-
ed by p53. As shown in Fig. 2, the phosphorylation of
serine 15 of wtp53 was observed 6 h after heating without
or with glycerol in A-172/neo cells (Fig. 2, the middle left
column, line 3 and 4), whereas it was not observed after
glycerol treatment alone (Fig. 2, the middle left column,
line 2). The phosphorylation of serine 15 after heating
with glycerol was suppressed by an inhibitor of wortman-
nin (20 µM) for PI3-K family (Fig. 2, the middle left col-
umn, lane 5). WAF1 was accumulated in relation to the
level of serine 15 phosphorylation (Fig. 2, the lower left
column). These results suggest that the PI3-K family such
as ATM, ATR or DNA-PK contributes to heat-induced acti-
vation of p53 at serine 15 as reported in radiation-induced
p53 activation [18–22]. In contrast to A-172/neo cells, A-
172/mp53/248 cells did not show any significant increase
of WAF1 6 h after heating (Fig. 2, the lower right column,
Figure 2
Suppression of heat-induced phosphorylation of serine15 of p53 and WAF1 accumulation by wortmannin. Western blotting
samples were prepared from A-172/mp53/248 cells 6 h after heating at 44°C for 30 min. Wortmannin was added 2 h before
heating at a final concentration of 20 µM.BMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/6
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line 3), although the serine 15 was phosphorylated (Fig.
2, the middle right column, line 3). When A-172/mp53/
248 cells were heated in the presence of glycerol, WAF1
was accumulated (Fig. 2, the lower right column, lane 4)
with the phosphorylation of the serine 15 (Fig. 2, the mid-
dle right column, lane 4). Wortmannin suppressed WAF1
accumulation and serine 15 phosphorylation after heat-
ing in the presence of glycerol (Fig. 2, the middle and low-
er right columns, lane 4). These results mean that the
phosphorylation of serine 15 of p53 is not sufficient for
the heat-induced mp53 activation. It is suggested that the
activation of mp53 demands both the reconstruction
process by glycerol and the heat-induced phosphorylation
process by the PI3-K family. In addition, it is suggested
that the glycerol-enhanced heat sensitivity of mp53 cells is
dependent on p53-dependent signal transduction and
mediated by p53-regulated Bax induction. Glycerol may
be universally effective against the expression of p53-reg-
ulated downstream genes in cells bearing mp53, because
restoration of mp53 to normal p53 by glycerol is observed
in Bax induction as well as WAF1 induction.
The function of wtp53 is depressed by mp53 in a way that
mp53 forms heterogeneous tetramer with wtp53. This ef-
fect of mp53 is the dominant negative effect [16,17]. From
this, one possibility is that glycerol may depress the dom-
inant negative effect of mp53 and p53-centered signal
transduction may be restored by glycerol. However, we
have already reported that WAF1 expression after heating
was induced in Saos-2 cells (p53-null) transfected with
mp53 gene [14], when the cells were pre-treated with glyc-
erol. WAF1 expression was not induced even after com-
bined treatment with heat and glycerol in the cells
transfected with neo vector alone without mp53 gene. At
least, mp53 is necessary for induction of WAF1 gene ex-
pression by heat in glycerol-treated cells. These results
strongly support that the conformation of mp53 was re-
stored to normal type of p53 by glycerol.
Furthermore, to confirm the conformational change of
mp53 to wtp53 suggested by Western blot analysis, the
DNA binding activity of p53 for p53CON was measured
in nuclear proteins extracted from A-172/neo or A-172/
mp53/248 cells using the gel mobility-shift assay. It is
known that wtp53 can bind to p53CON homologous to a
specific DNA sequence located upstream of the bax gene
which positively controls apoptosis [24]. In agreement of
this, the binding activity of wtp53 significantly increased
in A-172/neo cells treated with heat (44°C, 30 min) or
combination of heat and glycerol (0.6 M) (Fig. 3, the up-
per column, lane 3 and 4). In contrast, a slight increase in
the DNA binding activity of the nuclear proteins was ob-
served when A-172/mp53/248 cells were treated with heat
(44°C, 30 min) (Fig. 3, the lower column, lanes 3). The in-
crease may be due to endogenous wtp53 in A-172/mp53/
248 cells. The defective DNA binding ability of p53 from
heat-treated A-172/mp53/248 cells may be due to the
dominant negative nature of mp53 protein [16,17]. It is
known that mp53 has no ability to induce apoptosis, be-
cause most mp53 can not bind to a specific DNA sequence
[5,6]. On the other hand, when A-172/mp53/248 cells
were heated in the presence of glycerol (0.6 M) before
heating, they showed clear increased DNA binding activi-
ty of p53 to p53CON (Fig. 3, the lower column, lane 4).
This result shows that mp53 underwent conformational
change to wtp53. The enhanced heat sensitivity observed
in glycerol-pretreated A-172/mp53/143 cells (Fig. 1a)
might be induced through bax gene expression up-regulat-
ed by the activated mp53. No binding activity of p53 was
observed when whole cell proteins extracted from intact
A-172/neo or A-172/mp53/248 cells were treated with
heat, heat plus glycerol or heat plus glycerol plus wort-
mannin (Fig. 3, both columns, lanes 8, 9 and 10). Thus,
the acquisition of binding activity of wtp53 or glycerol-
treated mp53 is likely to demand cellular signal transduc-
tion as described above. Furthermore, the increased DNA
binding activity of nuclear proteins from A-172/neo or A-
172/mp53/248 cell was suppressed by wortmannin (Fig.
3, lane 5). This suggests that the PI3-K family mediates
glycerol-induced restoration of the DNA binding ability of
wtp53 and mp53 after heating. On Western blot analysis
(Fig. 2), phosphorylation of serine 15 seems to be re-
quired for this process.
New cancer therapies for patients with mp53-containing
tumors are recently being developed. Especially, reports
concerning to transfection of p53 gene into tumor [25–27]
and molecules which activate latent p53 [28], change the
conformation of mp53 [29] or restore the function of
mp53 [14,15,30,31]are on the increase. We have recently
reported that glycerol has an ability to restore normal
function to mp53, leading to WAF1 induction [14]. There-
after, new compounds which rescue mp53 conformation
and function have been reported by other laboratory [30].
Among the reported molecules, glycerol is easy to be rec-
ognized as the most useful molecule for cancer therapy,
because it is widely used as a convenient reagent in clini-
cal course already. Furthermore, as reported in this paper,
glycerol has an ability to enhance bax expression in mp53
cells as a chemical chaperone through phosphorylation of
p53 at serine 15 by PI3-K family and conformational
change of mp53. Thus, it is expected that the cancer ther-
apy combined hyperthermia and glycerol is efficient for
patients with mp53-containing tumors, in which p53-de-
pendent bax expression is less frequently induced.
As we have reported elsewhere [32], glycerol is also effec-
tive in inducing a conformational change of p53 and re-
storing normal function to mp53 (Fig. 4), leading to
enhanced radiosensitivity. The enhanced radiosensitivityBMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/6
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is closely related to the induction of p53-dependent apop-
tosis. Further, we have recently obtained results showing
that glycerol functions as a chemical chaperone in p53-de-
pendent CDDP sensitivity (unpublished data). Our re-
sults obtained from previous and the present studies show
that glycerol is available for cancer therapy such as hyper-
thermia, radiotherapy or chemotherapy which induces
the activation of p53 even in mp53 tumors.
Materials and Methods
Cells
Human glioblastoma A-172 cells (provided by JCRB, To-
kyo, Japan) were cultured at 37°C in Dulbecco's Modified
Eagle medium containing 10% (v/v) fetal bovine serum,
penicillin (50 U/ml), streptomycin (50 µg/ml) and kan-
amycin (50 µg/ml) (DMEM-10).
Plasmids
A-172 cells were transfected with the plasmids pC53-
SCX3, pC53-248 (mp53, point mutation from Val to Ala
at codon 143 or Arg and neomycin resistance marker) or
pCMV-Neo-Bam (neomycin resistance marker alone). Be-
fore transfection, these plasmids were digested with Hin-
dIII and linearized (plasmids were provided by Dr. B.
Vogelstein, Johns Hopkins Oncology Center, MD, USA).
A-172 cells were electroporated three times at 600 V with
linearized DNA (10 µg/10 µl of pC53-SCX3, pC53-248 or
pCMV-Neo-Bam). The transfectants (A-172/mp53/143,
transfected with pC53-SCX3; A-172/mp53/248, pC53-
248; A-172/neo, pCMV-Neo-Bam) were selected by G418
(200–400 µg/ml, Sigma Chemical Co., St. Louis, MO) and
incubated at 37°C through all experiments.
Glycerol treatment
Cells were treated with glycerol (at final concentration of
0.6 M) 48 h before heating (44°C, 30 min) and then were
Figure 3
Gel mobility-shift assay of nuclear extracts or whole cell extracts from A-172/neo or A-172/mp53/248 cells to p53CON. in
vivo, the cells were treated with glycerol (0.6 M), wortmannin (20 µM) and heat (at 44°C for 30 min). The nuclear fraction was
extracted from the treated cells 6 h after heating. in vitro, the whole cell extracts prepared from intact cells, and then they
were treated with glycerol, wortmannin and heat.BMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/6
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incubated at 37°C for 6 or 10 h in the presence of glycerol
until sampling. In the case of cell survival assay, the medi-
um with glycerol was changed with glycerol free one after
10 h incubation and thereafter cells were incubated for ten
to fourteen days at 37°C in glycerol free medium. In in vit-
ro treatment, whole cell extracts from intact cells were
treated with glycerol (at final concentration of 0.6 M) for
30 min at 37°C.
Wortmannin treatment
Cells were treated with wortmannin (Nacalai tesque, Inc.,
Kyoto, Japan, at final concentration of 20 µM) 2 h before
heating (44°C, 30 min) and then were incubated at 37°C
in the presence of wortmannin until sampling. In in vitro
treatment, whole cell extracts from intact cells were treat-
ed with wortmannin (at final concentration of 20µM)
during heating.
Cell survival assay
Cell survival after heating at 44°C for 0, 15, 30, 60, 90 or
120 min was quantitated by plating cells into 25 cm2 flask
containing the medium. Ten to fourteen days later, cell
colonies were rinsed with PBS, fixed with methanol,
stained with 2% Giemsa solution (Merck, Woodbridge,
NJ, USA). Colonies containing at least 50 cells were count-
ed. The number of cells per colony was determined prior
to experiment.
Western blotting analysis
Detailed procedure of Western blotting is described else-
where(El-Deiry et al., 1994). Aliquots (20 µg) of whole
cell extracts were used for Western blotting analysis of Bax
and p53. After electrophoresis on 15% (w/v) polyacryla-
mide gels containing 0.1% (w/v) SDS and electrophoretic
transfer onto Poly Screen PVDF membranes (DuPont/
NEN Research Products, Boston, MA), the proteins on
each membrane were incubated with the anti-human Bax
polyclonal antibody Ab-1 (Oncogene Science Inc., Union-
Figure 4
A schema showing restoration of normal p53 function by glycerol in mp53. Serine 15 of wtp53 and mp53 are phosphorylated
by the PI3-K family. Glycerol is effective in inducing conformational change of misfolding mp53 and renaturing mp53 to wtp53
which mediates heat sensitivity through bax expression.BMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/6
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dale, NY), anti-human p53 monoclonal antibody DO-1
(Oncogene Science Inc.), anti-human phosphorylated
p53 polyclonal antibody Phospho-p53 (Ser15) or anti-
human WAF1 monoclonal antibody EA10 (Oncogene Sci-
ence Inc.). The bands were visualized using horseradish
peroxidase-conjugated goat anti-rabbit (Santa Cruz Bio-
technology Inc., Santa Cruz, CA) or anti-mouse IgG anti-
body (Zymed Labs. Inc., San Francisco, CA) and the
BLAST®: Blotting Amplification System (DuPont/NEN Re-
search, Boston, MA).
Preparation of nuclear or whole cell extracts for gel mobil-
ity-shift assay
Nuclear extracts were prepared from A-172 transformed
cells 6 hr after heat treatment, heat and glycerol treat-
ments or no treatments as in vivo treatment samples. As in
vitro treatment samples, whole cell extracts were prepared
from intact A-172 transformed cells suspended in extrac-
tion buffer (20 mM HEPES-KOH, pH 7.6, 500 mM NaCl,
1.5 mM MgCl2, 0.2 mM EDTA-NaOH, pH 8.0, 0.5 mM
Dithiothreitol(DTT), 0.5 mM phenylmethyl-sulfanylfluo-
ride (PMSF), 25% (v/v) glycerol, 1.2 µM spermidine) and
were treated with glycerol (0.6 M), heat (44°C, 30 min) or
combination of glycerol and heat, and subsequently incu-
bated for 30 min at 37°C. The procedures of nuclear pro-
tein extraction are described previously[2]. Shortly, the
cells were washed with PBS and suspended in washing
buffer (10 mM Tris-HCl pH 7.5, 130 mM NaCl, 5 mM
KCl, 8 mM MgCl2) and then homogenized on ice in hy-
potonic buffer (20 mM HEPES-KOH, pH 7.6, 5 mM KCl,
0.5 mM MgCl2, 0.5 mM dithiothreitol (DTT), and 0.5 mM
phenylmethyl-sulfanylfluoride (PMSF) with a hand-driv-
en Dounce homogenizer. The homogenates were centri-
fuged to precipitate the nuclei, which were resuspended in
extraction buffer (20 mM HEPES-KOH, pH 7.6, 500 mM
NaCl, 1.5 mM MgCl2, 0.2 mM EDTA-NaOH, pH 8.0, 0.5
mM DTT, 0.5 mM PMSF, 25% (v/v) glycerol, 1.2 µM sper-
midine). The resulting nuclear suspensions were centri-
fuged to precipitate the chromatin and the nuclear extracts
were collected and dialyzed against binding buffer (20
mM HEPES-KOH, pH 7.6, 0.5 mM EDTA-NaOH, pH 8.0,
50 mM KCl, 0.5 mM DTT, 0.5 mM PMSF, 10% (v/v)glyc-
erol). The protein concentration of each extract was quan-
tified using a BIO-RAD Protein Assay Kit (Bio-Rad
Laboratories, Hercules, CA) with bovine serum albumin
as the standard.
Gel mobility-shift assay
The p53-p53CON binding activity was measured by a gel-
shift assay using a synthetic double-stranded DNA frag-
ment encoding the p53CON (5'-GGACATGCCCG-
GGCATGTCC-3') on the upstream of bax gene (Japan
Bioservice, Niiza, Saitama, Japan) as a probe. Detailed
procedure is described elsewhere [2]. The probe was la-
beled with [γ -32P]ATP using Megalabel (Takara Shuzo
Co., Ltd., Ohtsu, Shiga, Japan) and the required nuclear
extract (5 µg as protein) was incubated at 25°C for 30 min
with the labeled p53CON probe (1~3 ×  105 cpm) and
poly [dIdC]-poly [dIdC] (1 µg) (Pharmacia Biotech, Upp-
sala, Sweden) diluted with binding buffer to a final vol-
ume of 15 µl. After this incubation, the samples were
electrophoresed on a 5% (w/v) polyacrylamide gel for 1 h
at 150 V using Tris-acetate-EDTA buffer. Subsequently, the
gel was dried and observed with Fujix BAS 1000 Imaging
Analyzer (Fuji) and photographed on Pictrography 3000
(Fuji) connected to the BAS 1000.
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